Future Market Insights

Pediatric Vaccines Market Growth and Value Chain 2016-2026 by FMI

FMI’s New Report, titled, “Pediatric Vaccines Market: Global Industry Analysis and Opportunity Assessment 2016 - 2026” offers 10-year forecast and analysis.


Valley Cottage, NY -- (SBWIRE) -- 05/26/2016 -- Vaccination is a technique by which person is made immune or resistant to an infectious disease. Vaccination has saved millions of lives including adults, children, and animals, providing them a better quality and healthier life from various microorganism such as virus and bacteria. This is one of the most important reason behind the growth of this market. Vaccines stimulate the body's own immune system to protect the person against subsequent infection or disease. Vaccines are generally segmented into two target markets, adult and pediatric. Pediatric vaccines are commonly used for the immunization of children and adolescents against various various infectious diseases, like diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.

Pediatric Vaccines Market: Drivers and Restrains

Major growth drivers for the growth of global pediatric vaccines market are increasing private-public partnerships for the research and development activities, technological advancement in recombinant DNA technology, increasing healthcare expenditure. Both government and non-government bodies are focusing a lot on immunization campaigns to increase awareness about vaccination among population. However, rising costs of vaccines, low accessibility to remote areas and stringent regulation for approval of vaccines are some of the factors affecting the global pediatric vaccine.

Pediatric Vaccines Market: Segmentation

The global pediatric vaccines market can be segmented based on products, technology and types of diseases.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1317

Based on vaccines type, global pediatric vaccine market can be segmented into following:

Live, attenuated vaccines,
Inactivated/killed vaccines,
Toxoid vaccines
Recombinant vector vaccines

Based on diseases type, global pediatric vaccine can be segmented into following:

Hepatitis A
Hepatitis B
Haemophilus Influenzae type b (Hib)
Pneumococcal disease
Rotavirus(severe diarrhea)
Rubella(German measles)

Pediatric Vaccines Market: Overview

The pediatric vaccines market has reported a favorable growth due to increasing rate of birth around the world. The continuous occurrence of infectious diseases has created a high demand for pediatric vaccines market. Among all segments, the market of live, attenuated vaccines based on technology has reported a highest demand. By disease type, infectious diseases segment is one the segment of fastest growth in global pediatric market, in upcoming years.

Pediatric Vaccines Market: Regional Overview

Depending on geographic regions, global hypercalcemia market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. Geographically, North America is leading the global pediatric vaccines market because of high awareness among population for childhood vaccination. Asia Pacific is also one of the fasted growing region in global pediatric vaccines market due to high involvement of government-non-government bodies in promoting vaccination campaigns, and making available some of life saving pediatric vaccines on regular basis at free of cost. European market is about to grow due to increasing focus on technology innovation, translation research and development of pediatric vaccines, and expanding global co-operation among nations.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1317

Pediatric Vaccines Market: Key Player

Some of the major players operating in global pediatric vaccines market are Novartis, Medimmune, Pfizer, Sanofi, Merck, GlaxoSmithKline, Emergent Bio solutions, Bharat Biotech, Baxter International, Bavarian Nordic and AlphaVax.